Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Can-Fite BioPharma Ltd. See All Filings	D	2021-12-30 16:15:16 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-21-068127 Exclusions or Exemptions 506b Accepted Date 2021-12-30 16:15:16 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2020-07-17 16:30:21 UTC
Amount To Be Raised $3,411,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-20-017807 Exclusions or Exemptions 506b Accepted Date 2020-07-17 16:30:21 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2020-06-19 16:35:27 UTC
Amount To Be Raised $8,000,002 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-20-015364 Exclusions or Exemptions 506b Accepted Date 2020-06-19 16:35:27 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2020-01-24 16:40:44 UTC
Amount To Be Raised $2,400,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-20-001759 Exclusions or Exemptions 506b Accepted Date 2020-01-24 16:40:44 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2019-05-31 16:34:01 UTC
Amount To Be Raised $6,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-19-009894 Exclusions or Exemptions 506b Accepted Date 2019-05-31 16:34:01 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2019-04-11 16:30:31 UTC
Amount To Be Raised $3,200,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-19-006184 Exclusions or Exemptions 506b Accepted Date 2019-04-11 16:30:31 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2019-01-24 16:51:27 UTC
Amount To Be Raised $2,350,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-19-001167 Exclusions or Exemptions 506b Accepted Date 2019-01-24 16:51:27 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2018-03-22 16:05:43 UTC
Amount To Be Raised $5,000,004 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-18-003310 Exclusions or Exemptions 506b Accepted Date 2018-03-22 16:05:43 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2017-01-25 16:34:04 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-17-000661 Exclusions or Exemptions 506b Accepted Date 2017-01-25 16:34:04 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2015-10-28 00:00:00 UTC
Amount To Be Raised $4,825,002 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-15-008008 Exclusions or Exemptions 506b Accepted Date 2015-10-28 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2015-10-02 00:00:00 UTC
Amount To Be Raised $9,000,002 Associated Brokers / Dealers H.C. Wainwright & Co., LLC CIK Number 0001536196 Filed Document 0001213900-15-007433 Exclusions or Exemptions 506b Accepted Date 2015-10-02 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets Decline to Disclose Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2014-12-17 00:00:00 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers H.C. Wainwright & Co., LLC and ROTH Capital Partners, LLC CIK Number 0001536196 Filed Document 0001536196-14-000003 Exclusions or Exemptions 506b Accepted Date 2014-12-17 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $No Revenues Type of Security Option To Acquire
Can-Fite BioPharma Ltd. See All Filings	D	2014-03-24 00:00:00 UTC
Amount To Be Raised $5,059,072 Associated Brokers / Dealers ROTH Capital Partners, LLC CIK Number 0001536196 Filed Document 0001536196-14-000002 Exclusions or Exemptions 506b Accepted Date 2014-03-24 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business ISRAEL Revenue or Assets $No Revenues Type of Security Equity